BRIEF published on 03/19/2024 at 19:51, 2 years 4 months ago Eckert & Ziegler Announces Dividend Cut to Fund Future Investments Investment Eckert & Ziegler Financial Forecast Dividend Reduction Radiopharmaceuticals
BRIEF published on 03/19/2024 at 19:51, 2 years 4 months ago Eckert & Ziegler annonce une réduction de ses dividendes pour financer ses investissements futurs Investissement Eckert & Ziegler Prévisions Financières Réduction Des Dividendes Produits Radiopharmaceutiques
PRESS RELEASE published on 03/19/2024 at 19:46, 2 years 4 months ago EQS-Adhoc: Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024. Eckert & Ziegler reduces dividend to fund future investments, aiming for earnings growth in 2024. Details on financial performance and strategic moves disclosed Financial Performance Eckert & Ziegler Earnings Growth Dividend Reduction Strategic Investments
BRIEF published on 03/19/2024 at 10:58, 2 years 4 months ago Eckert & Ziegler Transitions to Societas Europaea Corporate Governance Shareholder Rights Eckert & Ziegler SE Societas Europaea Legal Transition
BRIEF published on 03/19/2024 at 10:58, 2 years 4 months ago Eckert & Ziegler rejoint Societas Europaea Société Européenne Gouvernance D'Entreprise Droits Des Actionnaires Eckert & Ziegler SE Transition Juridique
PRESS RELEASE published on 03/19/2024 at 10:53, 2 years 4 months ago Eckert & Ziegler Completes Change of Legal Form to SE Eckert & Ziegler completes change of legal form to SE, maintaining shareholder equity and operations. The company is a leading specialist in nuclear medicine and radiation therapy Eckert & Ziegler Legal Form SE Nuclear Medicine Radiation Therapy
BRIEF published on 02/28/2024 at 10:00, 2 years 5 months ago Eckert & Ziegler Étend Ses Activités sur le Ga-68 au Japon en Collaboration avec Novartis Eckert & Ziegler Imagerie Médicale Diagnostic Gallium-68 Novartis Pharma K.K.
BRIEF published on 02/28/2024 at 10:00, 2 years 5 months ago Eckert & Ziegler Expands Ga-68 Activities in Japan in Collaboration with Novartis Eckert & Ziegler Medical Imaging Diagnostic Gallium-68 Novartis Pharma KK
PRESS RELEASE published on 02/28/2024 at 10:00, 2 years 5 months ago Eckert & Ziegler Extends Ga-68 Activities in Japan Eckert & Ziegler extends Ga-68 activities in Japan in alliance with Novartis Pharma K.K. Clinical trial with GalliaPharm generator for Ga-68. Collaboration to enhance cancer therapies and diagnostics in Japan Eckert & Ziegler Clinical Trial Japan Ga-68 Radiopharmaceutical Industry
PRESS RELEASE published on 01/31/2024 at 14:00, 2 years 6 months ago Eckert & Ziegler to Supply Nucleus Radiopharma with Therapeutic Radioisotopes Ac-225 and Lu-177 Eckert & Ziegler to supply Nucleus Radiopharma with therapeutic radioisotopes Ac-225 and Lu-177 for cancer care, enabling advancement in radiotherapies and clinical development Cancer Care Eckert & Ziegler Nucleus Radiopharma Therapeutic Radioisotopes Radiotherapies
Published on 08/07/2026 at 23:15, 2 days 3 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 3 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 4 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 4 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 00:05, 2 hours 40 minutes ago Games of the Future Astana 2026 Comes to a Close After 12 Electric Days of Competition
Published on 08/09/2026 at 15:05, 11 hours 40 minutes ago GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/08/2026 at 16:25, 1 day 10 hours ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 2 days 3 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 18:54, 2 days 7 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 7 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 8 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 2 days 8 hours ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 2 days 8 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
